Back

A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome

1 May 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Basic science - Gene and cell therapy - Cytokines and inflammation - Molecular biology - Genetics Gene and cell therapy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Philippe Rouet

Rangueil Hospital of Toulouse, Toulouse (France)

8 More presentations in this session

Presentation thumbnail
Miss L. Zhang (Luxembourg, LU)
Abstract
Presentation thumbnail
Doctor M. Dziegala (Wroclaw, PL)
Abstract
Presentation thumbnail
Miss A. Voronova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor D. Kashtanova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor J. Ellenbroek (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Basic science - Gene and cell therapy - Cytokines and inflammation - Molecular biology - Genetics

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources